Filing Details
- Accession Number:
- 0001209191-13-051488
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-08 20:37:53
- Reporting Period:
- 2013-11-06
- Filing Date:
- 2013-11-08
- Accepted Time:
- 2013-11-08 20:37:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1337798 | Bradley G Cole | 301 Penobscot Drive Redwood City CA 94063 | Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-11-06 | 2,868 | $1.33 | 21,003 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-06 | 100 | $29.88 | 20,903 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-11-06 | 2,568 | $31.36 | 18,335 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-11-06 | 200 | $32.29 | 18,135 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-11-06 | 2,868 | $0.00 | 2,868 | $1.33 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-07-06 | No | 4 | M | Direct |
Footnotes
- The number of shares originally covered by the exercised option was 150,000 with an exercise price per share of $1.38. In connection with the issuer's initial public offering on October 4, 2005, a conditional dividend was issued which increased the number of shares covered by the option by 6,033 to 156,033, reducing the effective exercise price per share to $1.33.
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 20, 2012.
- Represents actual sale price.
- Includes 6,750 restricted stock units awarded on January 27, 2011, of which vest 1/3 of the shares vest on February 15, 2014, and 1/3 of the shares that vested on each of February 15, 2012 and 2013, net of withholding.
- Includes 6,700 restricted stock units awarded February 5, 2012,of which 1/3 vest on each of February 15, 2014 and 2015, and the 1/3 of the shares that vested on February 15, 2013, net of withholding.
- Includes 6,000 restricted stock units awarded July 25, 2013, of which 1/3 of the shares vest on each of February 15, 2014, 2015 and 2016.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $30.90 to $31.87.
- Represents weighted average sale price. Actual sale prices ranged from $32.25 to $32.32.
- The option became exercisable as to 25% of the shares on July 6, 2005, and became exercisable as to 1/48th of the shares each full month thereafter.
Billionaire Hedge Funds
